Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-81
Closed -$3.82K – 1441
2025
Q3
$3.82K Buy
+81
New +$3.91K ﹤0.01% 801
2025
Q2
– Sell
-345
Closed -$19.1K – 1788
2025
Q1
$19.1K Buy
345
+51
+17% +$2.76K ﹤0.01% 699
2024
Q4
$14.2K Buy
+294
New +$14.9K ﹤0.01% 457
2024
Q2
– Sell
-108
Closed -$5.25K – 752
2024
Q1
$5.25K Buy
+108
New +$5.27K ﹤0.01% 549
2023
Q4
– Sell
-115
Closed -$6.17K – 674
2023
Q3
$6.17K Buy
+115
New +$6.13K ﹤0.01% 509

Other funds holding SNY

SouthState Corp's SNY Position: Q4 2025 in Review

SouthState Corp sold out of Sanofi (SNY) in Q4 2025, closing a stake of 81 shares — an estimated $3.82K sold.

SouthState Corp first reported a position in SNY in Q3 2023 and held it in 5 quarters. The position peaked at $19.1K in Q1 2025. 758 funds tracked by Wall St. Rank hold SNY as of Q4 2025.

  • SouthState Corp reported no remaining Sanofi position as of Q4 2025 after selling out during the quarter.
  • SouthState Corp sold 81 Sanofi shares in Q4 2025, an estimated $3.82K.
  • SouthState Corp first reported a position in Sanofi in Q3 2023 and held it in 5 quarters.
  • SouthState Corp's Sanofi position peaked at $19.1K in Q1 2025.
  • 758 funds tracked by Wall St. Rank held Sanofi as of Q4 2025.

Based on SouthState Corp's 13F filing for Q4 2025, filed 11 Feb 2026.